08
décembre 2025
01:30 E.S.T.
Trial In Progress: Open-Label Dose-Finding and Dose-Expansion Study to Evaluate the Safety, Expansion, Persistence, and Clinical Activity of UCART20x22 in Subjects with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (B-NHL) NatHali-01_ASH 2025
Télécharger le PDF